Tirzepatide weight loss program Flow Wellness Hamburg NY

DUAL GIP/GLP-1 · MOST POPULAR

Tirzepatide Program: $800 for 10 Weeks

The dual-action GIP/GLP-1 receptor agonist that outperformed Semaglutide in clinical trials — delivering up to 22.5% body weight loss. Our most popular weight loss program, physician-supervised from day one.

THE SCIENCE

Why Tirzepatide Outperforms Semaglutide

Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist. While Semaglutide targets one pathway, Tirzepatide activates two — addressing both appetite regulation and metabolic efficiency simultaneously.

In the SURMOUNT clinical trials, patients on Tirzepatide achieved up to 22.5% body weight reduction — outperforming Semaglutide at every dosage level. Patients also showed improved insulin sensitivity, reduced triglycerides, and better cardiovascular markers.

At Flow Wellness, we prescribe pharmaceutical-grade compounded Tirzepatide with full physician supervision, personalized dosing, and ongoing lab monitoring — for $800 total over 10 weeks.

MOST POPULAR PROGRAM

Tirzepatide Program Includes:

✓ Free initial consultation
✓ Physician assessment & protocol design
✓ 10 weeks of pharmaceutical-grade Tirzepatide
✓ Dual GIP/GLP-1 mechanism
✓ Pre-measured, sterile injection supplies
✓ Step-by-step injection instructions
✓ Regular check-ins with our medical team
✓ Nutrition and lifestyle guidance
✓ Priority scheduling

$800

Complete 10-week program · No hidden fees

HEAD TO HEAD

Tirzepatide vs. Semaglutide: How They Compare

FEATURE

SEMAGLUTIDE

TIRZEPATIDE

Mechanism

GLP-1 only

GLP-1 + GIP (dual)

Avg. Weight Loss

15–17%

20–22.5%

Appetite Control

Strong

Superior

Insulin Sensitivity

Improved

Significantly improved

Flow Wellness Price

$500 / 10 wks

$800 / 10 wks

EXPECTED RESULTS

Your Tirzepatide Timeline

WEEKS 1–4

Rapid Appetite Suppression

Dual-action mechanism kicks in faster than single-pathway GLP-1s. Most patients notice significant reduction in hunger and food noise within days. Typical loss: 5–8 lbs.

WEEKS 5–8

Accelerated Metabolic Shift

Body composition changes become visible. Improved insulin sensitivity and metabolic efficiency. Patients frequently report needing new clothing sizes during this phase.

WEEKS 9–10+

Transformative Results

15–25+ lbs lost for most patients. Physician evaluates markers and recommends continuation or maintenance. Many patients choose to extend for maximum results.

PATIENT REVIEW

Tirzepatide Results

★★★★★

“I’ve been on the Tirzepatide package for three months and the results have been incredible. Down 22 pounds and I finally feel in control of my appetite. The team made everything so easy.”

— Jessica R.

TIRZEPATIDE PROGRAM

FAQ

Tirzepatide: Common Questions

Is Tirzepatide better than Semaglutide?

Clinical data shows Tirzepatide produces greater average weight loss (20–22.5% vs. 15–17% for Semaglutide). The dual GIP/GLP-1 mechanism provides enhanced appetite regulation and metabolic benefits. However, both are effective — the right choice depends on your goals and medical profile.

Why does Tirzepatide cost more than Semaglutide?

Tirzepatide is a newer, more complex molecule that costs more to compound. At $800 for 10 weeks ($80/week), our program is still significantly less expensive than brand-name Mounjaro ($1,000+/month) or most national telehealth providers.

Can I switch from Semaglutide to Tirzepatide?

Yes. Many patients who plateau on Semaglutide see renewed results after transitioning to Tirzepatide. Our physician will assess your progress and determine the best path forward.

What are the side effects of Tirzepatide?

Similar to Semaglutide: mild nausea, decreased appetite, and digestive changes in the first 1–2 weeks. Our conservative titration minimizes these effects. Most patients tolerate Tirzepatide well.

Start Tirzepatide program

Start Your Tirzepatide Program Today

$800 for 10 weeks. Dual-action GIP/GLP-1. Physician-supervised. Book your free consultation now.